These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862 [TBL] [Abstract][Full Text] [Related]
4. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer. Kusume T; Tsuda H; Kawabata M; Inoue T; Umesaki N; Suzuki T; Yamamoto K Clin Cancer Res; 1999 Dec; 5(12):4152-7. PubMed ID: 10632354 [TBL] [Abstract][Full Text] [Related]
5. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity. Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344 [TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224 [TBL] [Abstract][Full Text] [Related]
8. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation. Musgrove EA; Sarcevic B; Sutherland RL J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812 [TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778 [TBL] [Abstract][Full Text] [Related]
10. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407 [TBL] [Abstract][Full Text] [Related]
11. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4. Said TK; Luo L; Medina D Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159 [TBL] [Abstract][Full Text] [Related]
12. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Pagano M; Theodoras AM; Tam SW; Draetta GF Genes Dev; 1994 Jul; 8(14):1627-39. PubMed ID: 7958844 [TBL] [Abstract][Full Text] [Related]
15. Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation. Strasberg Rieber M; Rieber M Biochem Biophys Res Commun; 1995 Nov; 216(1):422-7. PubMed ID: 7488122 [TBL] [Abstract][Full Text] [Related]
16. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression. Wani G; Noyes I; Milo GE; D'Ambrosio SM Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589 [TBL] [Abstract][Full Text] [Related]
17. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112 [TBL] [Abstract][Full Text] [Related]
18. Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1. Beauchamp RD; Sheng HM; Shao JY; Thompson EA; Ko TC Ann Surg; 1996 May; 223(5):620-7; discussion 627-8. PubMed ID: 8651753 [TBL] [Abstract][Full Text] [Related]
19. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]